Skip to main content

Advertisement

SpringerLink
Log in

Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. van der Harst D, Goulmy E, Falkenburg J, Kooij-Winkelaar Y, van Luxemburg-Heijs S, Goselink H et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994; 83: 1060–1066.

    CAS  PubMed  Google Scholar 

  2. Hambach L, Goulmy E . Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005; 17: 202–210.

    Article  CAS  Google Scholar 

  3. Yunis J, Brunning R . Prognostic significance of chromosomal abnormalities in acute leukemias and myelodysplastic syndromes. Clin Haematol 1986; 15: 597–620.

    CAS  PubMed  Google Scholar 

  4. den Haan J, Meadows L, Wang W, Pool J, Blokland E, Bishop T et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054–1057.

    Article  CAS  Google Scholar 

  5. Pierce R, Field E, Mutis T, Golovina T, von Kap-Herr C, Wilke M et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223–3230.

    Article  CAS  Google Scholar 

  6. Brouwer R, van der Heiden P, Schreuder G, Mulder A, Datema G, Anholts J et al. Loss or Downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by Interferon. Hum Immunol 2002; 63: 200–210.

    Article  CAS  Google Scholar 

  7. Miyazaki M, Akatsuka Y, Nishida T, Fuji N, Hiraki A, Ikeda K et al. Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clin Immunol 2003; 107: 198–201.

    Article  CAS  Google Scholar 

  8. van Els C, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen P et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992; 35: 161–165.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was in part supported by the Dutch Cancer Society and the Deutsche Forschungsgemeinschaft. We thank Eric Spierings for fruitful discussions.

Author information

Authors and Affiliations

  1. Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

    L Hambach, J J M Drabbels & Els Goulmy

  2. Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands

    B A Nijmeijer & J H F Falkenburg

Authors
  1. L Hambach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B A Nijmeijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J J M Drabbels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J H F Falkenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Els Goulmy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Hambach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hambach, L., Nijmeijer, B., Drabbels, J. et al. Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy. Leukemia 20, 1298–1300 (2006). https://doi.org/10.1038/sj.leu.2404237

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404237

  • Springer Nature Limited

Search

Navigation